ES2183865T3 - Preparaciones de doble capa de galactolipido que contienen digalactosildiacilglicerol. - Google Patents

Preparaciones de doble capa de galactolipido que contienen digalactosildiacilglicerol.

Info

Publication number
ES2183865T3
ES2183865T3 ES95909184T ES95909184T ES2183865T3 ES 2183865 T3 ES2183865 T3 ES 2183865T3 ES 95909184 T ES95909184 T ES 95909184T ES 95909184 T ES95909184 T ES 95909184T ES 2183865 T3 ES2183865 T3 ES 2183865T3
Authority
ES
Spain
Prior art keywords
bicapas
preparation
galactolipido
digalactosildiacilglicerol
preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95909184T
Other languages
English (en)
Inventor
Anders Carlsson
Bengt Herslof
Snezana Petrovic-Kallholm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LIPOCORE HOLDING AB
Original Assignee
LIPOCORE HOLDING AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9400368A external-priority patent/SE9400368D0/xx
Priority claimed from SE9402455A external-priority patent/SE9402455L/xx
Application filed by LIPOCORE HOLDING AB filed Critical LIPOCORE HOLDING AB
Application granted granted Critical
Publication of ES2183865T3 publication Critical patent/ES2183865T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A61K8/064—Water-in-oil emulsions, e.g. Water-in-silicone emulsions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/005—Edible oil or fat compositions containing an aqueous phase, e.g. margarines characterised by ingredients other than fatty acid triglycerides
    • A23D7/0053—Compositions other than spreads
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L35/00—Food or foodstuffs not provided for in groups A23L5/00 – A23L33/00; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coils Or Transformers For Communication (AREA)
  • Magnetic Heads (AREA)
  • Cosmetics (AREA)
  • Organic Insulating Materials (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

ESTA INVENCION SE RELACIONA CON UNA PREPARACION EN BICAPAS DE UN SOLVENTE LIPIDICO POLAR FORMADO POR 0,01-90%, POR PESO, PREFERENTEMENTE ENTRE 0,1 Y 50%, DE UN MATERIAL FORMADOR DE BICAPAS EN UN SOLVENTE POLAR. EL MATERIAL FORMADOR DE BICAPAS ES UN MATERIAL GALACTOLIPIDICO OBTENIDO DE CEREALES QUE CONTIENE AL MENOS 50% DE DIGALACTOSILDIACILGLICEROLES, Y EL RESTO FORMADO POR LIPIDOS POLARES. LA PREPARACION EN BICAPAS PUEDE UTILIZARSE COMO VEHICULO PARA UNA SUSTANCIA ACTIVA EN UN PRODUCTO FARMACEUTICO, COSMETICO, ALIMENTICIO O DE USO AGRICOLA. LA INVENCION TAMBIEN SE REFIERE A UNA COMPOSICION FARMACEUTICA QUE CONSTA DE UNA SUSTANCIA TERAPEUTICAMENTE ACTIVA MEZCLADA CON LA PREPARACION EN BICAPAS MENCIONADA.
ES95909184T 1994-02-04 1995-02-06 Preparaciones de doble capa de galactolipido que contienen digalactosildiacilglicerol. Expired - Lifetime ES2183865T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9400368A SE9400368D0 (sv) 1994-02-04 1994-02-04 Glycolipid material
SE9402455A SE9402455L (sv) 1994-07-12 1994-07-12 Biskiktspreparat

Publications (1)

Publication Number Publication Date
ES2183865T3 true ES2183865T3 (es) 2003-04-01

Family

ID=26661955

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95909184T Expired - Lifetime ES2183865T3 (es) 1994-02-04 1995-02-06 Preparaciones de doble capa de galactolipido que contienen digalactosildiacilglicerol.

Country Status (19)

Country Link
US (1) US6022561A (es)
EP (1) EP0744939B1 (es)
JP (1) JP3203358B2 (es)
CN (1) CN1083713C (es)
AT (1) ATE224704T1 (es)
AU (1) AU691249B2 (es)
CA (1) CA2182576C (es)
DE (1) DE69528355T2 (es)
DK (1) DK0744939T3 (es)
ES (1) ES2183865T3 (es)
FI (1) FI963065A (es)
HU (1) HUT75459A (es)
MY (1) MY113341A (es)
NO (1) NO312494B1 (es)
NZ (1) NZ279953A (es)
PL (1) PL178438B1 (es)
PT (1) PT744939E (es)
TW (1) TW402502B (es)
WO (1) WO1995020944A1 (es)

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE504664C2 (sv) * 1995-09-22 1997-03-24 Scotia Lipidteknik Ab Sätt att framställa fraktionerad olja, oljan, dess användning samt emulsionskomposition innehållande oljan
AR013065A1 (es) * 1996-10-25 2000-12-13 Monsanto Technology Llc COMPOSICIoN Y METODO DE TRATAMIENTO PARA PLANTAS.
EP0941029B1 (en) 1996-10-25 2002-09-18 Monsanto Technology LLC Composition and method for treating plants with exogenous chemicals
WO1998020884A1 (fr) * 1996-11-08 1998-05-22 Takara Shuzo Co., Ltd. Inducteurs d'apoptose
WO1999012640A1 (en) * 1997-09-09 1999-03-18 Select Release, L.C. Coated particles, methods of making and using
EP1043016B1 (en) * 1999-03-30 2014-08-20 Sodic Sa A plant extract based on glycerides,phospholipids and phytosphingolipids, a method for the preparation of this extract and a cosmetic composition containing the same
FR2810540B1 (fr) * 2000-06-21 2004-04-30 C3D Nouvelles preparations cosmetiques ou hygieniques sous forme de dispersion
FR2814071A1 (fr) * 2000-09-21 2002-03-22 Oreal Composition a base de glycoglyceride et ses utilisations notamment cosmetiques
US6890255B2 (en) 2001-12-17 2005-05-10 Igt Multiple wheel roulette game
DK1499294T3 (da) * 2002-04-29 2010-12-06 Biotesys Gmbh Polymeriserede, peptid-modificerede lipider som biologiske transportsystemer til mikronæringsstoffer
US20040018237A1 (en) * 2002-05-31 2004-01-29 Perricone Nicholas V. Topical drug delivery using phosphatidylcholine
US7731947B2 (en) * 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
SE0300207D0 (sv) 2003-01-29 2003-01-29 Karolinska Innovations Ab New use and composition
DE10336841A1 (de) * 2003-08-11 2005-03-17 Rovi Gmbh & Co. Kosmetische Rohstoffe Kg Kosmetische Zusammensetzung zur Unterstützung des Sauerstofftransports in die Haut
SE0401942D0 (sv) * 2004-07-28 2004-07-28 Lipopeptide Ab New antimicrobial peptide complexes
KR101376895B1 (ko) 2004-05-03 2014-03-25 헤르메스 바이오사이언스, 인코포레이티드 약물 전달에 유용한 리포좀
US8658203B2 (en) 2004-05-03 2014-02-25 Merrimack Pharmaceuticals, Inc. Liposomes useful for drug delivery to the brain
US20050255154A1 (en) 2004-05-11 2005-11-17 Lena Pereswetoff-Morath Method and composition for treating rhinitis
EP1846444A2 (en) 2004-12-22 2007-10-24 Lipopeptide AB Agents inhibiting the cathelin-like protein cap18/ll-37
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
DE102005023640A1 (de) * 2005-05-19 2006-11-23 Beiersdorf Ag Wirkstoffkombinationen aus Glucosylglyceriden und einem oder mehreren partiell neutralisierten Ester von Monoglyceriden und / oder Diglyceriden gesättigter Fettsäuren mit Zitronensäure
DE102005023636A1 (de) * 2005-05-19 2006-11-23 Beiersdorf Ag Wirkstoffkombinationen aus Glucosylglyceriden und Kreatin und / oder Kreatinin
DE102006015544A1 (de) * 2006-03-31 2007-10-04 Kuhs Gmbh Topisch zu applizierende Zusammensetzung
KR101106510B1 (ko) 2006-05-30 2012-01-20 인타르시아 세라퓨틱스 인코포레이티드 투피스, 내부채널 삼투압 전달 시스템 유동 조절기
AU2007284759B2 (en) 2006-08-09 2010-10-28 Intarcia Therapeutics, Inc. Osmotic delivery systems and piston assemblies
WO2008084253A1 (en) * 2007-01-12 2008-07-17 Lipopeptide Ab Use of a galactolipid for wound and ulcer healing
RU2440097C2 (ru) 2007-04-23 2012-01-20 Интарсия Терапьютикс, Инк. Способ лечения диабета ii типа и ожирения, осмотическое устройство для доставки и способ его изготовления
US20090137497A1 (en) * 2007-11-23 2009-05-28 Beiersdorf Ag Active ingredient combinations of glucosyl glycerides and creatine and/or creatinine
DK2240155T3 (da) 2008-02-13 2012-09-17 Intarcia Therapeutics Inc Indretninger, formuleringer og fremgangsmåder til levering af flere gavnlige midler
US20090285882A1 (en) * 2008-04-22 2009-11-19 Jochen Weiss Stabilized Liposome Compositions and Related Methods of Use
EP2406361B1 (en) * 2009-03-11 2021-01-20 Swedish Oat Fiber AB Method for separating neutral and polar lipids and an oil rich in polar lipids
EP3735944A1 (en) 2009-09-28 2020-11-11 Intarcia Therapeutics, Inc. Rapid establishment and/or termination of substantial steady-state drug delivery
WO2011043008A1 (ja) * 2009-10-07 2011-04-14 パナソニック株式会社 人工脂質膜形成方法
UA111147C2 (uk) 2009-11-11 2016-04-11 Байєр Б.В. Способи та композиції для лікування або профілактики зовнішнього отиту
WO2011087403A1 (en) * 2010-01-18 2011-07-21 Lipidor Ab Alcoholysis of glycolipid and corresponding lysis product
US9237762B2 (en) 2010-05-24 2016-01-19 Swedish Oat Fiber Ab Aqueous dispersion comprising galactolipids and method for production thereof
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
JP2014508166A (ja) 2011-03-17 2014-04-03 トランスダーマル バイオテクノロジ インコーポレーテッド 局所的一酸化窒素システム及びその使用方法
US8871259B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Techniques and systems for treatment of neuropathic pain and other indications
US8871256B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and systems for treatment of inflammatory diseases with nitric oxide
US8871255B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment of skin and soft tissue infection with nitric oxide
US8871261B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Cancer treatments and compositions for use thereof
US8871262B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Compositions and methods for treatment of osteoporosis and other indications
US8871260B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and compositions for muscular and neuromuscular diseases
US8871257B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery
US8871258B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment and prevention of learning and memory disorders
US8871254B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system
US9295647B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9314433B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US9314422B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9687520B2 (en) 2013-03-13 2017-06-27 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9241899B2 (en) 2013-03-13 2016-01-26 Transdermal Biotechnology, Inc. Topical systems and methods for treating sexual dysfunction
US9320706B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9314423B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Hair treatment systems and methods using peptides and other compositions
US9339457B2 (en) 2013-03-13 2016-05-17 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9387159B2 (en) 2013-03-13 2016-07-12 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9750787B2 (en) 2013-03-13 2017-09-05 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9393264B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9314417B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9295637B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Compositions and methods for affecting mood states
US20140271938A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US20140271937A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9849160B2 (en) 2013-03-13 2017-12-26 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US20140271731A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9320758B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9393265B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US9724419B2 (en) 2013-03-13 2017-08-08 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9295636B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
MA44390A (fr) 2015-06-03 2019-01-23 Intarcia Therapeutics Inc Systèmes de mise en place et de retrait d'implant
CA3001467A1 (en) 2015-10-16 2017-04-20 Ipsen Biopharm Ltd. Stabilizing camptothecin pharmaceutical compositions
WO2017200943A1 (en) 2016-05-16 2017-11-23 Intarcia Therapeutics, Inc. Glucagon-receptor selective polypeptides and methods of use thereof
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
IL267736B2 (en) 2017-01-03 2024-03-01 Intarcia Therapeutics Inc Methods involving continuous administration of a GLP-1 receptor agonist and co-administration of a drug
CN110183500B (zh) * 2019-07-05 2022-09-09 湖北中医药大学 一种植物半乳糖脂的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US437567A (en) * 1890-09-30 Cash and parcel carrier
EP0009842B1 (en) * 1978-10-02 1982-11-10 THE PROCTER & GAMBLE COMPANY Liposomes for drug delivery and composition containing a liposome drug system
SE8206744D0 (sv) * 1982-11-26 1982-11-26 Fluidcarbon International Ab Preparat for kontrollerad avgivning av substanser
DE3778972D1 (de) * 1986-06-12 1992-06-17 Liposome Co Inc Mittel unter verwendung liposomverkapselter, nichtsteroider, antiinflammatorischer arzneistoffe.
US5234767A (en) * 1987-03-13 1993-08-10 Micro-Pak, Inc. Hybrid paucilamellar lipid vesicles
ATE92765T1 (de) * 1989-02-06 1993-08-15 Chiba Flour Milling Limulustest-positives pflanzenglykolipid und verfahren zur stimulierung des immunsystems eines tieres.

Also Published As

Publication number Publication date
JP3203358B2 (ja) 2001-08-27
TW402502B (en) 2000-08-21
ATE224704T1 (de) 2002-10-15
CA2182576A1 (en) 1995-08-10
NO963241L (no) 1996-08-02
CN1083713C (zh) 2002-05-01
DE69528355T2 (de) 2003-05-15
NO963241D0 (no) 1996-08-02
PL178438B1 (pl) 2000-04-28
MY113341A (en) 2002-01-31
EP0744939B1 (en) 2002-09-25
WO1995020944A1 (en) 1995-08-10
NZ279953A (en) 1998-02-26
FI963065A (fi) 1996-09-30
PT744939E (pt) 2003-02-28
CA2182576C (en) 2002-09-17
JPH09508414A (ja) 1997-08-26
PL315779A1 (en) 1996-12-09
FI963065A0 (fi) 1996-08-02
US6022561A (en) 2000-02-08
AU1723495A (en) 1995-08-21
EP0744939A1 (en) 1996-12-04
AU691249B2 (en) 1998-05-14
DK0744939T3 (da) 2003-02-03
CN1144478A (zh) 1997-03-05
DE69528355D1 (de) 2002-10-31
HUT75459A (en) 1997-05-28
HU9602146D0 (en) 1996-09-30
NO312494B1 (no) 2002-05-21

Similar Documents

Publication Publication Date Title
ES2183865T3 (es) Preparaciones de doble capa de galactolipido que contienen digalactosildiacilglicerol.
ES2145143T3 (es) Copolimeros elastomericos termoplasticos y composiciones que los contienen para el cuidado del cabello y de la piel.
ES2158084T3 (es) Preparaciones vehiculo lipofilicas.
ES2157307T3 (es) Composicion topica que contiene un antagonista de sustancia p.
AU7993800A (en) Bioadhesive nanoparticulate compositions having cationic surface stabilizers
AU570639B2 (en) Corticoid topical formulation
PE11495A1 (es) Copolimero elastomerico termoplastico injertado con silicona y composicion para el cuidado del cabello y de la piel que lo contiene
AU3955089A (en) Pharmaceutical composition comprising protein kinase c inhibitor and anti-cancer agent
ES2133426T3 (es) Combinaciones de productos activos fungicidas.
EP0009688A3 (en) Medicated animal food based on liver powder, process for its preparation and its use in combating animal diseases
DE69723671D1 (de) Cyclosüporin formulierung
FI820563L (fi) Antimykotiskt medel i form av stift med hoeg frisaettning av det aktiva aemnet
ATE253820T1 (de) Wirkstoffhaltige komposition sowie deren herstellung und verwendung
DE69430070D1 (de) Topische pharmazeutische zusammensetzungen die (s)-2-(4-isobutylphenyl) propionsaeure enthalten
FI955403A (fi) Valeltavia koostumuksia, jotka sisältävät polymeerimateriaalia, glykoleja ja glyseridejä
FI962056A0 (fi) Uusi farmaseuttinen koostumus stabiilin jauheen valmistamiseksi, joka sisältää asetyylisalisyylihapon ja metoklopramidin yhdistelmän käsittävän aktiivisen aineosan
DE69927260D1 (de) Topische pharmazeutische zusammensetzung zur behandlung von haut- oder zirkulatorischen krankheiten auf inflammatorischer, immun-, proliferativer oder degenerativer basis
AU4150489A (en) Micronised drug formulation
AU530678B2 (en) Phosphono-hydroxy-acetic acid
ES2074037T1 (es) Dimero de la lisozima y composiciones que lo contienen.
ATE205071T1 (de) Funktionelles sauerstoffhaltiges präparat enthaltend phospholipide und fluorcarbon
HUP9902415A2 (hu) Azonnal felszabaduló szilárd beadási formák és eljárás azok előállítására
SE9800730D0 (sv) New topical formulation II
ATE131031T1 (de) Zubereitung zur topischen anwendung.
ES2106689B1 (es) Nueva formulacion a base de acido hidroxicitrico (sales y derivados) y sus aplicaciones cosmeticas y farmaceuticas por via topica percutanea.